Leading Australian scientist at forefront of genetic breast cancer research wins major industry award

GSK Australia
  • Professor Georgia Chenevix-Trench becomes the 42nd winner of the GSK Award for Research Excellence 2022.
  • This year, Professor Chenevix-Trench was also named one of the most influential health figures in Queensland.
  • With over thirty years of experience in cancer genetics, Professor Chenevix-Trench is a world-renowned scientist who is at the forefront of cancer research in Australia.
  • With her collaborators, Professor Chenevix-Trench discovered over 240 regions of a genome that are likely to affect a person's risk of developing breast cancer.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).